Obese asthmatic patients fail to benefit from steroidsThe primary controller medication for asthma, glucocorticoids, is 40 percent less effective in obese and overweight asthmatic patients when compared to patients with normal weight, according to researchers at National Jewish Health.

A long-term study was initiated by Dr. Sutherland and his colleagues for evaluating the clinical effects of steroid resistance among overweight and obese asthma patients and further clarifying the signaling pathways involved.

The study by Associate Professor of Medicine E. Rand Sutherland, MD, MPH and his colleagues at National Jewish Health, appeared in an issue of the American Journal of Respiratory and Critical Care Medicine.